Medical Marijuana Inc Continues the National Educational Symposium Series in the San Diego Convention Center and Previews Its Star Cast of Speakers
March 22, 2010: 07:20 AM ET
Medical Marijuana Inc (PINKSHEETS: MJNA) is proud to announce the latest of its National Educational Symposium Series at the San Diego Convention Center on March 27, 2010. Featured prominent industry experts include Medical Marijuana Inc Chairman and CEO, Bruce Perlowin, longtime industry expert Don Wirkshafter, registered nurse and manager of THCF in Riverside, California, Lanny Swerdlow, and Americans For Safe Access’ Dan Ruderalis who will comment on recent events in San Diego and other areas. Attendees will have the opportunity to Interact with The Executive Officers of MJNA, who will be present and available for consultation.
Enjoy and educate yourself with a day of segmented Classes, Lectures and Consultations given by Legal Experts, Tax Advisers, Northern California Growers, Cooperative Founders, Medical Marijuana Physicians, Patient Testimonials and Caregivers. Classes on the History of Hemp, Cannabis, Marijuana around the World, the Political Climate and Not for Profit Structuring, Legal Compliance, Cannabis Cultivation & How to Quick Start Your Medical Marijuana Delivery Service.
A Private Screening of "How Weed Won The West" — directed by Kevin Booth the film maker who also produced "American Drug War" will be shown Saturday at 8:00 pm, followed by a SOCIAL NETWORKING EVENT Saturday night from 9:00 to 11:30 PM. To purchase your tickets online go to: http://www.medicalmarijuanaeducationalexpo.com. Tweet us at: http://www.twitter.com/medmarijuanainc
Medical Marijuana Educational Seminars
Additionally we are teaching an entirely New Business Opportunity for Anyone wanting to get into the Medical Marijuana industry. An entrepreneurial opportunity that is faster to get up and running and earning income; and one that is safer than opening a collective dispensary or grow operation with all the shifting laws and unsure and unstable battling political environments.
These kinds of seminars are filled with people wanting to learn how to enter the Medical Marijuana Business. Therefore, we will be presenting our ground breaking new Medical Marijuana Inc Educational Center Business Opportunity where the licensed Center owner receives a percentage of all tickets, products & services offered through them by licensor MJNA.
Recent events in the political climate in Las Vegas have made it challenging to hold a proper educational seminar there. For the time being, until Las Vegas takes a more positive stance in this area, and we have by ended our agreement with our current partner there, with plans to hold off the seminar for now.
Medical marijuana has developed a suite of solutions to deliver an efficient and secure infrastructure for the Medical Marijuana Industry that provides the tools to industry operators to effectively manage their businesses with the confidence that they are in full compliance.
The Stored Value Platform System provides verifiable solutions to manage the difficult task of revenue and taxation collection. The provisional patent pending Stored Value Platform System is further described at: http://www.MedicalMarijuanaInc.com/index/html
Scientific Research and Development
MJNA acquired 20 acres of land in the mountains of Southern California in order to develop a research facility targeting medical cannabis strains specific to a wide range of medical conditions. By diligently developing the most efficacious strains and matching those strains to ailments, such as glaucoma, MJNA is poised as the industry leader in medical cannabis genetic research.
Medical Products Division
Medical Marijuana Inc plans to explore the development of proprietary products into the pharmacological marketplace. The company plans to institute medically based research to eventually formulate medical products that will withstand the FDA approval process. Though this is a futuristic goal and the medical approval process is a lengthy one, various stages of progress on medicinal properties will be made public over time.
Other products that are perhaps less "medical" in nature will also be considered by the Division for public marketing. Progress reports will also be regularly made on the development of products that may foster health and wellness benefits. All products require certain studies be formally conducted in order to make claims of any benefit so derived and the Company’s Medical Products Division will be so charged with evaluation and study.
About Medical Marijuana, Inc.
Medical Marijuana Inc (PINKSHEETS: MJNA) the first US public company in the cannabis industry to have its shares traded in the US stock market, recognizes the vast and unequaled opportunities that exist in the rapidly expanding medical marijuana industry. The scientific recognition of marijuana as a powerful medicine, and as an effective, non-narcotic pain reliever, has brought Medical Marijuana use to the forefront of mainstream discussion thus opening the door for safe and lucrative investment opportunities while engaging in compassionate socio-economic models.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana Inc to be materially different from the statements made herein.